0001104659-21-067516.txt : 20210517 0001104659-21-067516.hdr.sgml : 20210517 20210517092211 ACCESSION NUMBER: 0001104659-21-067516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210513 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAREKH RAJESH B CENTRAL INDEX KEY: 0001429930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21928008 MAIL ADDRESS: STREET 1: ALCHESTER HOUSE, LANGFORD LANE STREET 2: NORTH WENDLEBURY CITY: BICHESTER STATE: X0 ZIP: OX6 ONS FORMER NAME: FORMER CONFORMED NAME: PAREKH RAJESH R DATE OF NAME CHANGE: 20080317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001035354 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 841368850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (858) 909-0749 MAIL ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Sevion Therapeutics, Inc. DATE OF NAME CHANGE: 20140930 FORMER COMPANY: FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC DATE OF NAME CHANGE: 19991006 FORMER COMPANY: FORMER CONFORMED NAME: NAVA LEISURE USA INC DATE OF NAME CHANGE: 19970310 4 1 tm2116620d4_4.xml FORM 4 X0306 4 2021-05-13 0 0001035354 Eloxx Pharmaceuticals, Inc. ELOX 0001429930 PAREKH RAJESH B C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2021-05-13 4 P 0 84776 1.35 A 171807 I See footnote Common Stock 2021-05-13 4 P 0 2381890 1.35 A 4827129 I See footnote Reflects the purchase of shares in the offering of Common Stock of Eloxx Pharmaceuticals, Inc. that is expected to close on May 18, 2021. Held directly by Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein. Held directly by Advent Life Sciences Fund II LP. Advent Life Sciences LLP is the manager of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein. /s/ Neil S. Belloff, Attorney-in-Fact 2021-05-17